60 Years after the market withdrawal
We accept responsibility for the Thalidomide tragedy.
With the 'Grünenthal Foundation for the Support of Thalidomide Affected People',
we support affected individuals in their efforts to live their lives as independent as possible.
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.Find out more in Grünenthal’s 2020/21 annual report
Working at Grünenthal means experiencing the impact you can have on the results we achieve and the lives of the patients we serve.
Make an impact.
Innovate for a world free of pain.
Visit our careers website